Medical Mycology Journal is a leading publication in the field of medical mycology, dedicated to advancing the understanding and treatment of fungal infections. Published by the Japanese Society of Medical Mycology, this journal serves as an essential resource for researchers, clinicians, and students alike. With an ISSN of 2185-6486 and an E-ISSN of 2186-165X, it aims to provide high-quality peer-reviewed articles focusing on clinical and epidemiological studies, diagnosis, and novel therapeutic approaches related to fungal pathogens. Operating under a Q3 ranking in Infectious Diseases and having consistently published significant findings since its establishment in 2011, the journal is pivotal for those working at the intersection of mycology and infectious disease management. Although currently non-open access, the journal's insights are vital for expanding knowledge in this critical area of healthcare, addressing pressing global health challenges linked to fungal infections.

Mycosphere is a premier open-access journal published by MYCOSPHERE PRESS, dedicated to advancing the field of mycology and contributing significant insights into ecological and plant sciences. Established in 2010 and headquartered in Guiyang, China, this journal has carved out a vital niche, achieving remarkable rankings in the Scopus database—#3 in Ecology, Evolution, Behavior and Systematics and #4 in Plant Science, both boasting a 99th percentile ranking. With an unwavering commitment to disseminating high-quality research, Mycosphere serves as a critical platform for researchers, professionals, and students alike, encouraging robust dialogue and collaborations across the global scientific community. The journal's accessibility, coupled with its impact factor and Q1 categorizations in 2023 for both ecology and plant sciences, substantiate its role as an essential resource for cutting-edge studies and innovations in the field.

JOURNAL DE MYCOLOGIE MEDICALE is a premier publication in the field of infectious diseases, particularly focusing on the study of mycology and its clinical implications. Published by MASSON EDITEUR, this esteemed journal is based in France and has been disseminating valuable research since its inception in 1994. With an ISSN of 1156-5233 and an E-ISSN of 1773-0449, it plays a critical role in advancing knowledge in mycological infections, positioning itself in the Q3 category for infectious diseases as per the 2023 quartiles. As indicated by its ranking in Scopus, ranking #142 out of 344 in the medicine-infectious diseases category, the journal maintains a prominent presence within the academic community, appealing to researchers, healthcare professionals, and students alike. Although access options are not open access, the journal endeavors to promote a deeper understanding of mycological studies that are crucial for combating ongoing and emerging infectious threats. As it continues to converge on new findings up to 2024, JOURNAL DE MYCOLOGIE MEDICALE remains an essential resource for those invested in the critical intersections of mycology and medicine.

MYCOTAXON is a peer-reviewed journal dedicated to the field of mycology, focusing on the taxonomy, systematics, and ecology of fungi. Published by MYCOTAXON LTD, this journal plays a crucial role in advancing our understanding of fungal biodiversity and its significance within various ecosystems. Although it currently does not offer open access options, its contributions are vital to the scientific community, especially with its established presence since 1989. With an HIndex reflecting its relevance and attracting a dedicated readership, MYCOTAXON is recognized within the Q4 quartile in both Ecology, Evolution, Behavior, and Systematics, and Plant Science categories as of 2023. This places it among a critical cohort of journals that contribute to the understanding of ecological dynamics and plant-fungal interactions. Researchers, professionals, and students can benefit from the insights provided in MYCOTAXON, making it an indispensable resource for anyone involved in the study of fungi.

Journal of Fungi is a premier open-access journal published by MDPI, dedicated to advancing the understanding of fungal biology in its myriad forms. Since its inception in 2015, it has become a vital resource in the fields of ecology, evolution, and plant sciences, attaining notable rankings in Scopus, including Q1 status in Ecology, Evolution, Behavior and Systematics, and Plant Science, with a Q2 ranking in Microbiology (medical). The journal fosters a collaborative platform for researchers, professionals, and students by providing unrestricted access to high-quality, peer-reviewed articles, which encourages the dissemination of innovative findings and methodologies relevant to fungal research. Designed to cater to a global audience, the Journal of Fungi has established its significance in the scientific community, especially from its base in Switzerland, where it continues to contribute to the ongoing discourse in mycology and beyond. With its commitment to open access since its launch and its continuous support for groundbreaking research, the journal plays a crucial role in driving forward the scientific inquiry and ecological awareness in fungal studies.

STUDIES IN MYCOLOGY is a premier journal dedicated to advancing research in the field of mycology, published by the renowned WESTERDIJK FUNGAL BIODIVERSITY INSTITUTE. With an impact factor that places it in the top quartile (Q1) of both Agricultural and Biological Sciences and Plant Science categories, it holds a prestigious position in the scientific community, ranking #1 out of 193 in its field as per Scopus metrics. Since its transition to Open Access in 2008, it has made significant strides in disseminating high-quality research widely, fostering a greater understanding of fungal biodiversity and its ecological impact. Covering a broad spectrum of topics related to mycology, the journal aims to provide researchers, professionals, and students with a platform for sharing innovative findings, stimulating academic discourse, and promoting collaborative efforts within this vital area of study. Hailing from the Netherlands, STUDIES IN MYCOLOGY serves as an invaluable resource for exploring the complexities of fungi, their interactions with various ecosystems, and their practical applications in agriculture and beyond.

MYCOSES is a renowned academic journal published by Wiley, specializing in the fields of Dermatology, Infectious Diseases, and general Medicine, with a commendable focus on mycological research and its clinical implications. Established in 1957, this journal has significantly contributed to advancing our understanding of fungal diseases, offering a platform for high-quality research that ranks among the top in its categories—achieving Q1 status in Dermatology and Q1 in Medicine (miscellaneous), while maintaining a strong Q2 ranking in Infectious Diseases. With an impressive Scopus ranking of #5 in Medicine - Dermatology, MYCOSES occupies a pivotal position in the dissemination of critical findings and innovative practices within the scientific community. Although it is not an open-access journal, MYCOSES continues to attract a wide array of researchers, professionals, and students seeking to enhance their knowledge and keep abreast of the latest developments in mycology. Overall, MYCOSES not only serves as an essential resource for academia but also plays a vital role in shaping future research directions and clinical approaches to fungal infections.

Medical Mycology Case Reports, published by Elsevier, is a pivotal journal dedicated to advancing the field of mycology through the presentation of case reports that highlight clinical findings, diagnostic challenges, and treatment outcomes associated with fungal infections. With its ISSN 2211-7539 and E-ISSN 2211-7539, this open-access journal has been serving the global community since 2012, allowing unrestricted access to its valuable insights. Situated in the Netherlands, specifically at RADARWEG 29, AMSTERDAM, this journal has gained recognition in areas such as Infectious Diseases (ranked Q3) and Microbiology (ranked Q4) as of 2023. Its commitment to disseminating high-quality research is reflected in its Scopus rankings, which place it at the 51st percentile in Medicine and the 32nd percentile in Immunology and Microbiology. By bridging the gap between clinical cases and academic research, Medical Mycology Case Reports plays a crucial role in enriching the knowledge base of practitioners and researchers alike, ultimately contributing to improved patient management and public health.

IMA Fungus is an esteemed open-access journal published by BMC, dedicated to advancing research in the fields of fungi, plant sciences, and ecological systems. With an ISSN of 2210-6340 and E-ISSN 2210-6359, this journal has been an influential platform since its inception in 2010, contributing significantly to the scientific community in the United States and beyond. The journal’s remarkable impact can be seen in its Q1 quartile rankings across multiple categories, including Agricultural and Biological Sciences, Ecology, Evolution, Behavior and Systematics, and Plant Science, positioning it among the top literary sources in these fields. Notably, IMA Fungus holds impressive Scopus rankings, with the Agricultural and Biological Sciences category placing it in the 98th percentile, evidencing its crucial role in disseminating impactful research. Given its commitment to fostering accessibility and collaboration, IMA Fungus continues to be an invaluable resource for researchers, professionals, and students aiming to explore and understand the complex roles of fungi within various ecosystems.

MEDICAL MYCOLOGY, published by Oxford University Press, is a premier journal dedicated to the study of fungal infections and their clinical implications. With an ISSN of 1369-3786 and an E-ISSN of 1460-2709, this journal has established itself as a vital resource in the fields of Infectious Diseases and Medicine, holding a respectable Q2 ranking for both categories and a Q1 ranking in the veterinary sector in 2023. Spanning a rich history from 1962 to 2024, MEDICAL MYCOLOGY serves as a platform for innovative research, case reports, and review articles that contribute to the understanding and management of mycological diseases. The journal's commitment to advancing knowledge is reflected in its Scopus rank of #120 out of 344 in Medicine - Infectious Diseases, positioning it within the 65th percentile. With open access options available, it aims to ensure that critical research is accessible to a global audience, enhancing collaboration and knowledge sharing among researchers, healthcare professionals, and students alike.